BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2021
View Archived Issues
Chimerix opens enrollment in phase III study of dociparstat for AML
Read More
Macrophages dampen neuropathic pain
Read More
Collagen means well in pancreatic cancer
Read More
China's NMPA clears initiation of phase III trial of socazolimab for ES-SCLC
Read More
MacroGenics opens enrollment in phase II study of enoblituzumab in SCCHN
Read More
POPLAR study of imsidolimab in palmoplantar pustulosis does not meet primary endpoint
Read More
SBI and University of Oxford initiate phase II study of cardioprotective agent using 5-ALA
Read More
FDA clears IND for UX-053 for treatment of glycogen storage disease type III
Read More
Health Canada approves Estelle as first native estrogen-based combined oral contraceptive
Read More
Injecting sRNAs from the putamen of HD patients reproduces associated neuropathology in mice
Read More
Idorsia Pharmaceuticals patents LGALS3 inhibitors
Read More
Artios Pharma divulges POLQ inhibitors
Read More
Chinese investigators identify new TGFBR1 inhibitors
Read More
KalVista Pharmaceuticals presents KLKB1 inhibitors
Read More
Ivermectin does not significantly improve the time to resolution of symptoms in mild COVID-19
Read More
Clene Nanomedicine updates on clinical studies of CNM-Au8 gold nanocrystals
Read More
Bayer and DKFZ patent AhR antagonists
Read More
IL-17 receptor's "B team" may be pancreatic cancer target
Read More
Cell-based aHyC vaccine shows promise for treating patients with CRPC
Read More
Phase III CANOPY-2 trial of canakinumab in locally advanced or metastatic NSCLC misses OS endpoint
Read More
ASC-40 reduces liver fat in phase II China cohort in NASH
Read More
Xenon collaborates with Mount Sinai on phase II study of XEN-1101 for MDD and anhedonia
Read More
FDA clears IND for pivotal study of KN-046 for thymic carcinoma
Read More
AEON initiates phase II study of ABP-450 for preventive treatment of migraine
Read More
New model for invasive lobular carcinoma points to LOXL1 as a therapeutic target
Read More
